AU4445201A - Method for administering insulin to the buccal region - Google Patents

Method for administering insulin to the buccal region

Info

Publication number
AU4445201A
AU4445201A AU44452/01A AU4445201A AU4445201A AU 4445201 A AU4445201 A AU 4445201A AU 44452/01 A AU44452/01 A AU 44452/01A AU 4445201 A AU4445201 A AU 4445201A AU 4445201 A AU4445201 A AU 4445201A
Authority
AU
Australia
Prior art keywords
administering insulin
buccal region
buccal
region
insulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44452/01A
Inventor
Pankaj Modi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generex Pharmaceuticals Inc
Original Assignee
Generex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/538,829 external-priority patent/US7070799B1/en
Application filed by Generex Pharmaceuticals Inc filed Critical Generex Pharmaceuticals Inc
Publication of AU4445201A publication Critical patent/AU4445201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU44452/01A 2000-03-30 2001-02-21 Method for administering insulin to the buccal region Abandoned AU4445201A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09538829 2000-03-30
US09/538,829 US7070799B1 (en) 1998-02-10 2000-03-30 Method for administering insulin to the buccal region
PCT/IB2001/000564 WO2001072278A2 (en) 2000-03-30 2001-02-21 Method for administering insulin to the buccal region

Publications (1)

Publication Number Publication Date
AU4445201A true AU4445201A (en) 2001-10-08

Family

ID=24148588

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44452/01A Abandoned AU4445201A (en) 2000-03-30 2001-02-21 Method for administering insulin to the buccal region

Country Status (2)

Country Link
AU (1) AU4445201A (en)
WO (1) WO2001072278A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275778T3 (en) * 2002-06-06 2007-06-16 Chiesi Farmaceutici S.P.A. SOLUBILIZATION OF PHARMACOS IN HFA PROPULSORS THROUGH EMULSIONS.
FR2854072B1 (en) * 2003-04-23 2006-08-04 Centre Nat Rech Scient VECTOR FOR ORAL ADMINISTRATION
GB2430881B (en) 2005-10-06 2010-10-13 Ntnu Technology Transfer As Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity
GB0707096D0 (en) 2007-04-12 2007-05-23 Ntnu Technology Transfer As Method
GB0904942D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
GB0904941D0 (en) 2009-03-23 2009-05-06 Ntnu Technology Transfer As Composition
US11166912B2 (en) * 2016-03-03 2021-11-09 Ctt Pharma Inc. Orally administrable composition
CN107583047A (en) * 2017-09-15 2018-01-16 广东海大畜牧兽医研究院有限公司 A kind of fish oral vaccine adjuvant and its formulation method
US11298336B2 (en) 2019-05-30 2022-04-12 Soluble Technologies, Inc. Water soluble formulation
US11786475B2 (en) 2020-07-22 2023-10-17 Soluble Technologies Inc. Film-based dosage form

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109350A (en) * 1993-05-12 2001-01-28 Genentech Inc Stable liquid compositions of gamma interferon
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5653987A (en) * 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
US6312665B1 (en) * 1998-12-21 2001-11-06 Generex Pharmaceuticals Incorporated Aerosol formulations for buccal and pulmonary application

Also Published As

Publication number Publication date
WO2001072278A2 (en) 2001-10-04
WO2001072278A3 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
TWI315201B (en) Acidic insulin preparations having improved stability
AU2001289309A1 (en) Improved safety syringe
AU2002248464A1 (en) Stabilized insulin formulations
IL158862A0 (en) An insulin composition for pulmonary administration
IL137105A0 (en) Method for administering aspb28-human insulin
AU2955200A (en) Cannula
AU5259100A (en) Medicament
AU2002222853A1 (en) Therapeutic compounds
HUP0204109A3 (en) Oral preparations for diabetes
AU2001278755A1 (en) Injections
AU2001274548A1 (en) Syringe
AU2002253039A1 (en) Tramadol-based medicament
AU2001272293A1 (en) Device for administering an injectable product
AU2001290239A1 (en) Medicinal composition
AU4445201A (en) Method for administering insulin to the buccal region
EP1272240B8 (en) Hypodermic syringe
AU2001258550A1 (en) Insulin formulation for inhalation
AU1541601A (en) Syringes
AU2001286341A1 (en) Therapeutic bio-energy unit
AU2001278323A1 (en) Modified sialic acid vaccines
AU2002213420A1 (en) Single-use syringe
AU2002240004A1 (en) Infusion cannula
ZA200210361B (en) Method of administering bishosphonates.
AU2204101A (en) Tooth extractor
AU2000279374A1 (en) Secure syringe

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase